Clinical Trials
5 trialsNCT05442554 2025-09-18
A Study of Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma
Takeda
Phase 4 Completed
NCT01990534 2021-04-09
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
Takeda
Phase 4 Completed
NCT02996617 2016-12-19
PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia
Shandong Provincial Hospital
Phase 4 Unknown
NCT02938741 2016-10-25
ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4 Unknown
NCT00211198 2008-03-05
Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)
Eisai Inc.
Phase 4 Completed